- Home
- PLX vs INFU Comparison
PLX vs INFU Comparison
Compare PLX & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | INFU |
|---|---|---|
| Founded | 1993 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 197.0M |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PLX | INFU |
|---|---|---|
| Price | $2.67 | $12.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 757.1K | 97.7K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | ★ 0.27 | 0.20 |
| Revenue | $52,744,000.00 | ★ $143,436,000.00 |
| Revenue This Year | $36.81 | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $9.69 | $60.50 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.53 | $7.29 |
| 52 Week High | $3.19 | $12.97 |
Technical Indicators
Market Signals| Indicator | PLX | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 60.82 |
| Support Level | $2.59 | $11.79 |
| Resistance Level | $2.71 | $12.97 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 87.78 | 43.66 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.